Add a Comment By Allyson Collins, MS, Science Writer/Editor   |  Wednesday, May 8, 2013 Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005. read more

View original post here:
Physicians and Scientists at Memorial Sloan-Kettering Pioneer the Development of Kidney Cancer Treatments

Scroll to Top